![]() Lion TCR Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases. | ![]() Adagene Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy. | ![]() Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. | |
Founding Date | Founding Date N/A | Founding Date 2012 | Founding Date 2013 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Singapore, SG HQ Guangzhou, CN Singapore, SG Singapore, SG | Locations Suzhou, CN HQ San Diego, US San Francisco, US | Locations San Diego, US HQ Zug, CH |
Employees | Employees N/A | Employees 13821% decrease | Employees 666% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) $12.4m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $600k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $7.7m (FY, 2025) | Gross profit $11.8m (FY, 2022) |
Net income | Net income N/A | Net income ($17.6m) (FY, 2025) | Net income ($740.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 155m | Total funding raised N/A |

Adagene is an antibody discovery and development biotechnology company specializing in oncology immunotherapy.
View company
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
View company